We have continued our studies of the insulin-like growth factors (IGFs), their receptors, and binding proteins (IGFBPs) to understand the physiological and pathological role of the IGFs. IGF-I and IGF-II in plasma and other extracellular fluids occur complexed to IGFBPs, a family of at least 6 proteins that are thought to modulate IGF actions. We believe that a major component of this regulation occurs at the level of IGFBP synthesis in different tissues. The IGFBP-2 gene is expressed at higher levels in fetal than in adult rat tissues, especially liver, and persists in adult choroid plexus. IGFBP-2 mRNA is increased in liver in diabetes, fasting and growth hormone deficiency. We have isolated and characterized clones encoding the rat IGFBP-2 gene. Its promoter region lacks a TATA box, but contains potential cis regulatory elements for insulin regulation and liver-specific expression. Transcription of the IGFBP-1 gene is increased in diabetic rat liver, and decreased after insulin treatment. IGFBP-1 mRNA also is increased in fetal rat liver after maternal food deprivation. We have studied the regulation of IGFBP-1 gene expression in a model system, the well-differentiated H4-II-E rat hepatoma cell line. In H4-II-E cells, IGFBP-1 gene transcription is increased by the synthetic glucocorticoid dexamethasone, and rapidly (<20 min) decreased by physiological concentrations of insulin. The mammalian IGF-II/Mannose-6-phosphate receptor is a bifunctional receptor that binds IGF-II and proteins containing mannose-6-phosphate recognition markers (such as lysosomal enzymes). Chick embryo fibroblasts contain a primitive form of this receptor. It is the same size as and immunologically related to the mammalian IGF-II/Man 6-P receptor, binds and internalizes lysosomal enzymes, but does not bind IGF-II.

Project Start
Project End
Budget Start
Budget End
Support Year
18
Fiscal Year
1991
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Adams, Ted D; Davidson, Lance E; Litwin, Sheldon E et al. (2017) Weight and Metabolic Outcomes 12 Years after Gastric Bypass. N Engl J Med 377:1143-1155
Adams, Ted D; Davidson, Lance E; Litwin, Sheldon E et al. (2012) Health benefits of gastric bypass surgery after 6 years. JAMA 308:1122-31
Kolotkin, Ronette L; Davidson, Lance E; Crosby, Ross D et al. (2012) Six-year changes in health-related quality of life in gastric bypass patients versus obese comparison groups. Surg Obes Relat Dis 8:625-33
Hammoud, Ahmad O; Walker, James M; Gibson, Mark et al. (2011) Sleep apnea, reproductive hormones and quality of sexual life in severely obese men. Obesity (Silver Spring) 19:1118-23
Kolotkin, Ronette L; LaMonte, Michael J; Litwin, Sheldon et al. (2011) Cardiorespiratory fitness and health-related quality of life in bariatric surgery patients. Obes Surg 21:457-64
Wasmund, Stephen L; Owan, Theophilus; Yanowitz, Frank G et al. (2011) Improved heart rate recovery after marked weight loss induced by gastric bypass surgery: two-year follow up in the Utah Obesity Study. Heart Rhythm 8:84-90
Hunt, Steven C; Hasstedt, Sandra J; Xin, Yuanpei et al. (2011) Polymorphisms in the NPY2R gene show significant associations with BMI that are additive to FTO, MC4R, and NPFFR2 gene effects. Obesity (Silver Spring) 19:2241-7
Benraouane, Fethi; Litwin, Sheldon E (2011) Reductions in cardiovascular risk after bariatric surgery. Curr Opin Cardiol 26:555-61
Adams, Ted D; Pendleton, Robert C; Strong, Michael B et al. (2010) Health outcomes of gastric bypass patients compared to nonsurgical, nonintervened severely obese. Obesity (Silver Spring) 18:121-30
Hammoud, Ahmad; Carrell, Douglas T; Meikle, A Wayne et al. (2010) An aromatase polymorphism modulates the relationship between weight and estradiol levels in obese men. Fertil Steril 94:1734-8

Showing the most recent 10 out of 22 publications